Shareholder alert: weiss law investigates aerie pharmaceuticals, inc.

New york , aug. 23, 2022 /prnewswire/ -- weiss law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of aerie pharmaceuticals, inc. ("aerie" or the "company") (nasdaq: aeri), in connection with the proposed acquisition of the company by alcon inc. (nyse: alc).  under the terms of the merger agreement, the company's shareholders will receive $15.25 in cash for each share of aerie common stock owned.
ALC Ratings Summary
ALC Quant Ranking